Trial In Progress: The Phase Iii, Randomized, Open-Label, Multicenter Commodore 1 Study Evaluating The Efficacy And Safety Of Crovalimab Versus Eculizumab In Adult And Adolescent Patients With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With Complement Inhibitors
BLOOD（2020）
摘要
Background
更多查看译文
关键词
crovalimab versus eculizumab,paroxysmal nocturnal hemoglobinuria,complement inhibitors,adolescent patients,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要